DUALITYBIO-B

09606
93.2504.16% ( -4.050 )
Delay Closed: Nov 17, 16:08:15

Shareholders

All Shareholders

Shareholder Type

  • Institutions55.54%
  • VC/PE firms21.70%
  • Individuals & Insiders13.01%
  • Public companies4.79%
  • Others4.97%

Major Shareholders

Major Shareholders Latest
Shareholder
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
14.64%13.26M0.07%+105.00K
Zhongyuan ZhuCEO & Chairman
7.53%6.81M0.24%+220.00K
Xiamen Yinglian Health Industry Investment Management Co., Ltd.
7.05%6.39M0.02%+0
King Star Med Management Limited
4.97%4.50M0.02%+0
Wuxi Biologics Healthcare Venture
4.61%4.17M0.02%+0
Fei Chen
4.15%3.76M0.01%+0
CICC Private Equity Investment Management Co., Ltd.
3.70%3.35M0.01%+0
Sino Biopharmaceutical Limited
3.68%3.33M0.01%+0
Wellington Management Group LLP
3.32%3.01M0.02%-520.00
E Fund Management Co., Ltd.
2.94%2.66M<0.01%+804.00
Suzhou Oriza Holdings Co., Ltd.
2.77%2.51M<0.01%+0
Vanguard Capital Management, LLC
2.66%2.41M<0.01%+8.10K
Green Pine Capital Partners Co., Ltd.
2.07%1.88M<0.01%+0
China Universal Asset Management Company Ltd.
2.00%1.81M<0.01%+0
Capital Research and Management Company
1.99%1.80M0.83%+751.20K
Suzhou Huagai Yizhen Equity Investment Partnership (Limited Partnership)
1.89%1.72M<0.01%+0
Sw Biotech I Lpf
1.85%1.67M<0.01%+0
Bank of China Investment Management Co., Ltd.
1.84%1.67M<0.01%+0
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)
1.66%1.51M<0.01%+0
Xiamen Qisheng Venture Capital Co., Ltd.
1.66%1.51M<0.01%+0